Amphastar Pharmaceuticals, Inc.: gross profit

What this measure means

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Exact concept: us-gaap:GrossProfit. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Amphastar Pharmaceuticals, Inc.: total assets
• Amphastar Pharmaceuticals, Inc.: total liabilities
• Amphastar Pharmaceuticals, Inc.: stockholders equity
• Amphastar Pharmaceuticals, Inc.: cash and cash equivalents
• Amphastar Pharmaceuticals, Inc.: net income or loss
• Amphastar Pharmaceuticals, Inc.: operating cash flow
• Amphastar Pharmaceuticals, Inc.: capital expenditure payments
• Amphastar Pharmaceuticals, Inc.: revenue
• Amphastar Pharmaceuticals, Inc.: financing cash flow
• Amphastar Pharmaceuticals, Inc.: investing cash flow
• Amphastar Pharmaceuticals, Inc.: retained earnings or deficit
• Amphastar Pharmaceuticals, Inc.: basic weighted-average shares
• Amphastar Pharmaceuticals, Inc.: diluted weighted-average shares
• Amphastar Pharmaceuticals, Inc.: basic earnings per share
• Amphastar Pharmaceuticals, Inc.: diluted earnings per share
• Amphastar Pharmaceuticals, Inc.: income tax expense or benefit
• Amphastar Pharmaceuticals, Inc.: net property, plant and equipment
• Amphastar Pharmaceuticals, Inc.: share-based compensation expense
• Amphastar Pharmaceuticals, Inc.: operating income or loss
• Amphastar Pharmaceuticals, Inc.: current assets
• Amphastar Pharmaceuticals, Inc.: interest expense
• Amphastar Pharmaceuticals, Inc.: current liabilities
• Amphastar Pharmaceuticals, Inc.: current accounts payable
• Amphastar Pharmaceuticals, Inc.: goodwill carrying amount
• Amphastar Pharmaceuticals, Inc.: net finite-lived intangible assets
• Amphastar Pharmaceuticals, Inc.: net current accounts receivable
• Amphastar Pharmaceuticals, Inc.: common-stock repurchase payments
• Amphastar Pharmaceuticals, Inc.: operating expenses
• Amphastar Pharmaceuticals, Inc.: net inventory
• Amphastar Pharmaceuticals, Inc.: cost of revenue
• Amphastar Pharmaceuticals, Inc.: research and development expense

Inspect the source

Entity

Amphastar Pharmaceuticals, Inc. / CIK 0001297184

Captured

2026-09-20T07:50:28.316Z

SEC response SHA-256

4edb9fcf1f4d33d8901a1aee21727ab07b6978219daa713c8278848d43d84326

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001297184.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))